Ligand validation:8IR8

HTG: heptyl 1-thio-beta-D-glucopyranoside

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8IR8_HTG_B_624	77%	42%	0.105	0.945	1.01	1.22	2	4	0	0	100%	1
8IR8_HTG_b_625	73%	33%	0.104	0.929	1.07	1.57	2	4	0	0	100%	1
8IR8_HTG_o_301	41%	30%	0.157	0.87	1.16	1.6	2	6	0	0	100%	1
8IR8_HTG_b_622	38%	24%	0.164	0.867	1.15	1.95	2	8	0	0	100%	1
8IR8_HTG_B_622	22%	44%	0.251	0.869	0.81	1.36	1	1	0	0	100%	1
8IR8_HTG_c_523	16%	36%	0.265	0.839	0.97	1.54	1	2	0	0	100%	1
8IR8_HTG_C_522	11%	45%	0.335	0.849	0.86	1.27	1	1	0	0	100%	1
8IR8_HTG_d_411	7%	33%	0.309	0.789	1	1.64	1	1	0	0	84%	0.8421
8IR8_HTG_V_202	6%	61%	0.421	0.924	0.36	1.12	-	1	0	0	58%	0.5789
8IR8_HTG_D_410	5%	35%	0.277	0.724	1.06	1.47	2	1	0	0	84%	0.8421
8IR8_HTG_b_623	2%	27%	0.469	0.772	1.08	1.85	1	2	0	0	100%	1
5V2C_HTG_O_303	94%	33%	0.072	0.972	1.58	1.07	2	2	0	0	100%	1
3WU2_HTG_O_303	89%	37%	0.092	0.971	1.17	1.32	2	1	0	0	100%	1
8IR7_HTG_b_625	81%	37%	0.086	0.939	0.97	1.5	2	3	0	0	100%	1
8IR6_HTG_b_625	81%	35%	0.088	0.941	1.07	1.48	2	4	0	0	100%	1
8IRA_HTG_B_625	81%	46%	0.097	0.95	0.97	1.12	2	2	0	0	100%	1
8IR9_HTG_B_623	81%	45%	0.098	0.95	0.99	1.13	2	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.